EP
WGS icon

Essential Partners’s GeneDx Holdings WGS Stock Holding History

Essential Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78K Buy
55
+19
+53% +$1.08K ﹤0.01% 1673
2026
Q1 		$2.31K Sell
36
-8
-18% -$729 ﹤0.01% 1947
2025
Q4 		$5.72K Buy
44
+5
+13% +$686 ﹤0.01% 1378
2025
Q3 		$4.2K Buy
39
+3
+8% +$327 ﹤0.01% 1491
2025
Q2 		$3.32K Buy
+36
New +$2.83K ﹤0.01% 1165

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Essential Partners's WGS Position: Q2 2026 in Review

Essential Partners increased its GeneDx Holdings (WGS) stake by 53% in Q2 2026, buying an estimated $1.08K and bringing the position to 55 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

Essential Partners first reported a position in WGS in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.72K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Essential Partners held 55 shares of GeneDx Holdings worth $3.78K as of Q2 2026.
  • Essential Partners bought 19 GeneDx Holdings shares in Q2 2026, an estimated $1.08K.
  • GeneDx Holdings made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1673 holding.
  • Essential Partners first reported a position in GeneDx Holdings in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's GeneDx Holdings position peaked at $5.72K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.